This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
We compare the top Sp 500 index funds by their expense ratios and total fees to help you locate the lowest-cost choice for retirement.
28,029 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
As 2026 unfolds, investors debate whether ripple worth holding through the year hinges on regulatory clarity, adoptio...
A fresh SummerFi attack on its automated Lazy Summer vaults raises questions about AI-driven risk in DeFi as guardian...
Ripple seals a multi-year Kansas Athletics partnership, pushing XRP into the sports spotlight. Traders watch for real...
Binance releases its June proof of reserves, revealing higher Bitcoin balances against a backdrop of weaker stablecoi...
United Airlines is set to report Q2 results after the market closes, with investors weighing fuel costs against peak ...
A seasoned executive faces a high-stakes choice: take a startup role or ride out the final years with a steady path. ...
Berkshire Hathaway slashed its Amazon holding by 77% in the fourth quarter, leaving a lean position and sparking rene...
When a CEO unloads a big chunk of stock, investors take note. This article digs into sentinelone's sold over 39,000 s...
White House aides are weighing a federal retirement savings vehicle for workers without access to employer plans, wit...
Rocket Lab posted solid Q4 FY2025 revenue above estimates, while warning that the Neutron program faces a timeline sh...
As geopolitical tensions rise, energy prices and cyber threats intensify. This could push firms toward poly-national ...